Currently out of the existing stock ratings of Ross Muken, 63 are a BUY (65.63%), 30 are a HOLD (31.25%), 3 are a SELL (3.13%).

Ross Muken

Work Performance Price Targets & Ratings Chart

Analyst Ross Muken, currently employed at EVERCORE, carries an average stock price target met ratio of 82.72% that have a potential upside of 15.5% achieved within 516 days.

Ross Muken’s has documented 191 price targets and ratings displayed on 29 stocks. The coverage is on Healthcare, Financial Services sectors.

Most recent stock forecast was given on CRL, Charles River Laboratories at 06-Aug-2026.

Wall Street Analyst Ross Muken

Analyst best performing recommendations are on PDCO (PATTERSON COMPANIES).
The best stock recommendation documented was for PDCO (PATTERSON COMPANIES) at 6/21/2018. The price target of $18.5 was fulfilled within 1 day with a profit of $0.73 (4.11%) receiving and performance score of 41.08.

Average potential price target upside

of $62 on Q (QUINTILES TRANSNATIONAL).
of $28.48 (20.03%) on MCK (MCKESSON).
of $27.49 (13.62%) on ILMN (ILLUMINA).

DGX Quest Diagnostics ICLR ICON PLC MCK McKesson PDCO Patterson Companies RAD Rite Aid A Agilent Technologies ABC AmerisourceBergen ATHN athenahealth CAH Cardinal Health HSIC Henry Schein WBA Walgreens Boots Alliance CERN Cerner Corp ILMN Illumina IQV IQVIA Holdings LH Laboratory of America Holdings Q Quintiles Transnational QGEN Qiagen NV TMO Thermo Fisher Scientific TWST Twist Bioscience Corp EHTH eHealth CRL Charles River Laboratories CVS CVS Health Corp DHR Danaher MDRX Allscripts Healthcare Solutions PINC Premier WAT Waters ONVO Organovo Holdings BRKR Bruker MTD Mettler-Toledo International

Show more stocks

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Lisa Gill (JPMORGAN)